Envista (NYSE:NVST – Get Free Report) is expected to release its earnings data after the market closes on Wednesday, February 5th. Analysts expect Envista to post earnings of $0.23 per share and revenue of $646.28 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
Envista Price Performance
Shares of NVST stock opened at $20.51 on Monday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The company has a market capitalization of $3.53 billion, a P/E ratio of -2.64, a P/E/G ratio of 1.89 and a beta of 1.33. The company’s 50-day simple moving average is $20.08 and its two-hundred day simple moving average is $19.03. Envista has a one year low of $15.15 and a one year high of $24.79.
Wall Street Analysts Forecast Growth
NVST has been the subject of several recent analyst reports. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised their target price on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Mizuho initiated coverage on shares of Envista in a research note on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 target price for the company. Stifel Nicolaus raised their target price on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and raised their price target for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, Envista has a consensus rating of “Hold” and an average price target of $20.13.
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles
- Five stocks we like better than Envista
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Overbought Stocks Explained: Should You Trade Them?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- ETF Screener: Uses and Step-by-Step Guide
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.